The Binding Site Group, Ltd.: Medical Device Recalls in 2019

Updated on March 25, 2026.

According to to data from the FDA, there was 1 medical device recall made by The Binding Site Group, Ltd. in 2019. See the detail of the recall below.

You can see similar recalls for other firms.

Data Source: FDA.

See this for other years:

Optilite C-Reactive Protein Kit - Product Usage: The Optilite C-Reactive Protein Reagent is intended for the quantitative in vitro determination of C-reactive protein (CRP) concentration in serum using the Binding Site Optilite analyser. Measurement of C-Reactive Protein aids in evaluation of the amount of injury to body tissues and for evaluation of infection, tissue injury, and inflammatory disorders. This test should be used in conjunction with other laboratory and clinical findings. The Optilite C-Reactive Protein Calibrator is intended for the calibration of the Optilite C-Reactive Protein Reagent on the Optilite analyser. The Optilite C-Reactive Protein Controls are intended for use in quality control by monitoring accuracy and precision for the Optilite C-Reactive Protein Reagent.